Picture of Novo Nordisk A/S logo

NVO — Novo Nordisk A/S News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Brief: CHMP Recommends Granting Marketing Authorisation For Frehemgo, Vaxrabeo, Adcomfo & Pebrilzo

BRIEF-CHMP Recommends Granting Marketing Authorisation For Frehemgo, Vaxrabeo, Adcomfo & Pebrilzo

- EMA's CHMP:

  • EMA'S CHMP: RECOMMENDED GRANTING A MARKETING AUTHORISATION FOR FREHEMGO (DENECIMIG)

  • EMA'S CHMP: RECOMMENDED GRANTING A MARKETING AUTHORISATION FOR VAXRABEO

  • EMA'S CHMP: RECOMMENDS GRANTING MARKETING AUTHORISATION FOR ADCOMFO & PEBRILZO


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Novo Nordisk A/S

See all news